ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024
Creation of Wood-Based Hierarchical Superstructures via In Situ Growth of ZIF-8 for Enhancing Mechanical Strength and Electromagnetic Shielding Performance.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- MOF-derived carbon materials for efficient electromagnetic interference shielding.RSC advances · 2026Review
- FeMn-MOF@Bamboo Carbon Synergy: Lightweight Composites for Versatile and High-Efficiency Electromagnetic Protection.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
- Environmentally sustainable fabrication of high-performance M-type hexaferrite BaFeScientific reports · 2026Article
- In Situ Growth of Metal-Organic Frameworks (MOFs) Within Porous Silicon Carbide (p-SiC) for Constructing Hierarchical Porous Composites.Nanomaterials (Basel, Switzerland) · 2026Article
- High Electrical Conductivity Induced by Surface Confinement Effect in Heterostructured Multifunctional Nanofiber Composite Films for Low-Reflection Electromagnetic Interference Shielding.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- Creation of Wood-Based Hierarchical Superstructures via In Situ Growth of ZIF-8 for Enhancing Mechanical Strength and Electromagnetic Shielding Performance.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Given the escalating prevalence of electromagnetic pollution, there is an urgent need for the development of high-performance electromagnetic interference (EMI) shielding materials. Herein, wood-based electromagnetic shielding materials have gained significant popularity due to their exceptional performance as building materials. In this study, a novel wood-based composite with electromagnetic shielding properties is developed. Through the in situ growth of zeolitic imidazolate framework-8 (ZIF-8) crystals on wood fibers, coupled with uniform integration of carbon nanotubes (CNTs), a multifunctional composite named ZIF-8/Poplar-CNT composite is synthesized via a one-step thermoforming process. The incorporation of CNTs endows the composites with excellent EMI shielding effectiveness (EMI SE). Among these elements, despite ZIF-8 crystals not possessing intrinsic electromagnetic shielding functionality, their distinctive dodecahedral structure proves adept at scattering and reflecting electromagnetic waves within the composites, further improving the electromagnetic shielding effect. Hence, the ZIF-8/Poplar-CNT composite (56.95 dB) has ≈10 dB higher EMI SE compared to that of the composites without ZIF-8 crystals. Meanwhile, ZIF-8 crystals endow the materials with excellent tensile strength (54.84 MPa, enhanced by 4 times). Moreover, the introduction of Zn
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.